Study of Birth Control Use After Childbirth
This study is a randomized controlled trial that will evaluate the impact of a brief educational script on the method of birth control that women receive at their 6-week postpartum visit. The one-minute script ("LARC script") is given to women in the hospital during their postpartum admission. It informs patients about long-acting reversible contraceptive (LARC) methods, specifically the contraceptive implant and the intrauterine device. The investigators hypothesize that women who are randomized to receive the LARC script will be more likely to report that they are using a LARC method, when queried immediately after their six-week postpartum visit.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Investigator, Outcomes Assessor)
Primary Purpose: Prevention
|Official Title:||A Randomized Controlled Trial of a Brief Educational Script on Postpartum Contraceptive Uptake|
- Self-reported use of LARC method [ Time Frame: After six-week postpartum visit ] [ Designated as safety issue: No ]
- Self-reported interest in use of a LARC method [ Time Frame: After six-week postpartum visit ] [ Designated as safety issue: No ]
- Self-reported use of any contraceptive method [ Time Frame: After six-week postpartum visit ] [ Designated as safety issue: No ]
- Self-reported reasons for not using the contraceptive method of choice [ Time Frame: After six-week postpartum visit ] [ Designated as safety issue: No ]
|Study Start Date:||May 2011|
|Study Completion Date:||May 2012|
|Primary Completion Date:||May 2012 (Final data collection date for primary outcome measure)|
Experimental: LARC script
Received routine postpartum counseling and LARC script.
Behavioral: LARC Script
The LARC Script is a one-minute educational script that describes long-acting reversible contraceptive methods.
No Intervention: No LARC script
Received only routine postpartum counseling
Please refer to this study by its ClinicalTrials.gov identifier: NCT01443533
|United States, North Carolina|
|Raleigh, North Carolina, United States, 27610|